We are very proud of this result. A no‑483 outcome is a testament to the discipline, expertise, and dedication of our ...
ALEXANDRIA, VA ProcellaRX, LLC today released “The Reinvention Lab: A Vision for the Future of Digital Validation 2030,” ...
The first industry-designed accreditation dedicated specifically to the safe, compliant, and human-supervised use of AI ...
With a clear pathway toward FDA submission and strong execution underway, we believe BlinkLab is well positioned to transform how autism is assessed in clinical practice.” — BlinkLab CEO and Managing ...
Nia Therapeutics announced that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to its Smart Neurostimulation System (SNS) for the treatment of episodic memory loss ...
Drug developers will be able to use alternatives to animal testing and possibly get new products to market faster under draft guidance issued Wednesday by the FDA. In a press release, officials said ...
FIRST ON FOX: The Food and Drug Administration (FDA) rolled out a new platform, backed by artificial intelligence, that will streamline publicly accessible reporting of negative or unexpected health ...
Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions that the ...
FDA Rare Diseases FILE - President Donald Trump listens as Dr. Marty Makary, commissioner of the Food and Drug Administration, speaks in the Roosevelt Room of the White House, Monday, Sept. 22, 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results